Clinical trial
Buprenorphine's Dose Response Curve
NCT00460239 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00460239 |
|---|---|
| Title | Buprenorphine's Dose Response Curve |
| Official title | Evaluation of Opioid Antagonist Activity in Humans |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine, Morphine, Placebo |
| Enrollment | 12 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Apr 13, 2007 |
| Last update posted | Mar 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: